ASBP Aspire Biopharma Holdings, Inc.

Fundamentals / CIK 0001847345 / USD
Other share classes on CIK 0001847345: ASBPW

Aspire Biopharma Holdings, Inc. reported $6.2K in revenue and a net loss of $11.05M for the fiscal year ended December 31, 2025, with a -1.9% gross margin and a -118015.3% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open ASBP in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

4 fiscal years (2022 to 2025), reported in USD.

$6.98M$3.49M$0-$23.27MFY 2022 Net Income: $3.34M2022FY 2023 Net Income: $4.46M2023FY 2024 Net Income: -$1.31M2024FY 2025 Revenue: $6.2KFY 2025 Net Income: -$24.48M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31
Revenue $6.2K -- -- --
Cost of Revenue $6.3K -- -- --
Gross Profit -$116 -- -- --
Research & Development $924K $144K -- --
Selling, General & Admin $18.43M $1.07M -- --
Total Operating Expenses $19.35M $1.21M $1.34M $976K
Operating Income -$19.35M -$1.21M -- --
Interest Income -- $549K $5.81M $4.32M
Interest Expense $8.53M $98K $9.0K --
Income Before Tax -$24.48M -$1.31M -- --
Income Tax Expense -- $1.0K -- --
Net Income -$24.48M -$1.31M $4.46M $3.34M
Diluted EPS -$16.38 -$1.90 -- --
Basic Shares Outstanding 1.5M 689.9K -- --
Diluted Shares Outstanding 1.5M 689.9K -- --

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Revenue $63K $28K -- $1.9K -- -- -- --
Cost of Revenue $51K $23K -- $1.1K -- -- -- --
Gross Profit -$30K $5.8K -- $884 -- -- -- --
Research & Development $233K $297K $100K $208K $353K $263K $116K $7.0K
Selling, General & Admin $2.19M $1.36M $1.75M $938K $447K $15.29M $551K $208K
Total Operating Expenses $2.65M $1.65M $1.85M $1.15M $800K $15.56M $668K $215K
Operating Income -$2.68M -$1.65M -$1.85M -$1.15M -$800K -$15.56M -- -$215K
Interest Income $57K $5.0K -- -- -- -- $67K $77K
Interest Expense $0 $1.60M $6.23M $1.48M $528K $290K -- --
Income Before Tax -$1.27M -$3.22M -- -- -$1.98M -$15.94M -- --
Income Tax Expense -- -- -- -- -- -- -- $1.0K
Net Income -$1.27M -$3.22M -$4.71M -$1.85M -$1.98M -$15.94M -$766K -$216K
Basic EPS -$1.22 -$20.57 -- -$0.04 -$48.19 -$504.88 -- -$0.01
Diluted EPS -$1.22 -$20.57 -- -$0.04 -$48.19 -$504.88 -- -$0.01
Basic Shares Outstanding 1.0M 156.7K -- 49.5M 41.1K 31.6K -- 27.6M
Diluted Shares Outstanding 1.0M 156.7K -- 49.5M 41.1K 31.6K -- 27.6M

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $1.00M $3.6K -- $497K --
Cash & Short-Term Investments $1.00M $3.6K -- $497K --
Inventory $253K -- -- -- --
Total Current Assets $1.31M $148K $81K $1.10M $293K
Total Non-Current Assets $0 $0 $19.90M $299.1M $0
Total Assets $1.31M $148K $19.98M $300.2M $293K
Accounts Payable $1.01M $310K -- -- --
Other Current Liabilities $354K $111K $239K $123K --
Total Current Liabilities $7.59M $1.69M $403K $303K $294K
Total Non-Current Liabilities $96K $0 $0 $10.81M $0
Total Liabilities $7.69M $1.69M $403K $11.12M $294K
Common Stock $12 $69 -- -- --
Retained Earnings -$27.26M -$2.78M -$11.29M -$9.94M -$25K
Total Stockholders' Equity -$6.38M -$1.54M -$488K -$9.94M -$475
Total Equity -$6.38M -$1.54M -$488K -$9.94M -$475

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Cash & Cash Equivalents $12.17M $5.86M $1.00M $1.95M $206K $1.35M $3.6K --
Cash & Short-Term Investments $12.17M $5.86M $1.00M $1.95M $206K $1.35M $3.6K --
Inventory $288K $370K $253K $35K -- -- -- --
Total Current Assets $13.47M $7.12M $1.31M $2.40M $989K $1.97M $148K $62K
Total Non-Current Assets $75K $0 $0 $0 $0 $0 $0 $6.60M
Total Assets $13.54M $7.12M $1.31M $2.40M $989K $1.97M $148K $6.66M
Accounts Payable $972K $858K $1.01M $1.06M $1.35M $1.43M $310K --
Other Current Liabilities -- -- $354K -- -- $354K $111K $329K
Total Current Liabilities $1.69M $3.15M $7.59M $13.86M $10.56M $8.87M $1.69M $6.57M
Total Non-Current Liabilities $97K $96K $96K $9.9K $49K $49K $0 $0
Total Liabilities $1.78M $3.25M $7.69M $13.87M $10.61M $8.92M $1.69M $6.57M
Common Stock $129 $17 $12 $5.0K $5.0K $4.9K $69 --
Retained Earnings -$31.75M -$30.48M -$27.26M -$22.55M -$20.70M -$18.72M -$2.78M -$15.38M
Total Stockholders' Equity $11.76M $3.87M -$6.38M -$11.47M -$9.62M -$7.95M -$1.54M -$774K
Total Equity $11.76M $3.87M -$6.38M -$11.47M -$9.62M -$7.95M -$1.54M -$774K

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$24.48M -$1.31M $4.46M $3.34M
Stock-Based Compensation $14.13M $0 -- --
Change in Inventory -$253K -- -- --
Change in Payables -$324K $248K -- --
Operating Cash Flow -$4.92M -$265K -$653K -$1.41M
Investing Cash Flow -- $13.78M $284.9M -$294.7M
Common Stock Issued -- $258K -- --
Share Repurchases -- -$13.78M -$284.9M --
Financing Cash Flow $5.92M $258K -$284.8M $296.6M
Net Change in Cash $1.00M -$7.5K -$497K $497K

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Net Income -$1.27M -$3.22M -$4.71M -$1.85M -$1.98M -$15.94M -$766K -$216K
Stock-Based Compensation $144K $13K $0 $0 $0 $14.13M -- $0
Change in Inventory $39K -$117K -- -- -- -- -- --
Change in Payables $128K -$140K -$47K -$1.32M -$80K $1.12M $316K -$57K
Operating Cash Flow -$2.12M -$3.04M -$928K -$1.10M -$1.14M -$1.75M $480K -$496K
Common Stock Issued $9.00M $8.95M -- -- -- -- $0 $0
Financing Cash Flow $8.43M $7.89M -$17K $2.85M $0 $3.09M -$492K $492K
Net Change in Cash $6.31M $4.85M -$944K $1.74M -$1.14M $1.34M -$13K -$3.1K

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31
Gross Margin -1.9% -- -- --
Operating Margin -312016.9% -- -- --
Net Profit Margin -394725.1% -- -- --
Return on Assets (ROA) -1865.7% -885.1% 22.3% 1.1%
Current Ratio 0.17x 0.09x 0.20x 3.62x
Quick Ratio 0.14x 0.00x -- 1.64x
Net Income Growth (YoY) -- -129.3% +33.6% --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Return on Equity (ROE) -94.0% -304.1% -- -- -- -- -- --
Return on Assets (ROA) -81.6% -165.3% -1865.7% -854.7% -1910.7% -865.9% -885.1% -10.4%
Current Ratio 7.99x 2.26x 0.17x 0.17x 0.09x 0.22x 0.09x 0.01x
Quick Ratio 7.81x 2.14x 0.14x 0.17x 0.02x 0.15x 0.00x --
Operating Cash Flow Growth (YoY) -- -- -293.5% -- -- -- -- --
Source: SEC EDGAR CompanyFacts (CIK 0001847345) · from March 31, 2021 Data through June 30, 2026 · synced Nov 21, 2026, 05:13 UTC · Open in terminal